Determination of the half-life of circulating leptin in the mouse

Background: The adipokine hormone, leptin, is a major component of body weight homeostasis. Numerous studies have been performed administering recombinant mouse leptin as an experimental reagent; however, the half-life of circulating leptin following exogenous administration of recombinant mouse lep...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Obesity Vol. 41; no. 3; pp. 355 - 359
Main Authors Burnett, L C, Skowronski, A A, Rausch, R, LeDuc, C A, Leibel, R L
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2017
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: The adipokine hormone, leptin, is a major component of body weight homeostasis. Numerous studies have been performed administering recombinant mouse leptin as an experimental reagent; however, the half-life of circulating leptin following exogenous administration of recombinant mouse leptin has not been carefully evaluated. Methods: Exogenous leptin was administered (3 mg leptin per kg body weight) to 10-week-old fasted non-obese male mice and plasma was serially collected at seven time points; plasma leptin concentration was measured by enzyme-linked immunosorbent assay at each time point to estimate the circulating half-life of mouse leptin. Results: Under the physiological circumstances tested, the half-life of mouse leptin was 40.2 (±2.2) min. Circulating leptin concentrations up to 1 h following exogenous leptin administration were 170-fold higher than endogenous levels at fasting. Conclusions: The half-life of mouse leptin was determined to be 40.2 min. These results should be useful in planning and interpreting experiments employing exogenous leptin. The unphysiological elevations in circulating leptin resulting from widely used dosing regimens for exogenous leptin are likely to confound inferences regarding some aspects of the hormone’s clinical biology.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Rudolph L. Leibel rl2332@cumc.columbia.edu, Columbia University Department of Pediatrics Division of Molecular Genetics, Naomi Berrie Diabetes Center, New York Obesity Research Center
Charles A. LeDuc, cal8@cumc.columbia.edu, Columbia University Department of Pediatrics Division of Molecular Genetics, Naomi Berrie Diabetes Center, New York Obesity Research Center
Lisa Cole Burnett, lmc2200@cumc.columbia.edu, Columbia University Institute of Human Nutrition, Columbia University Department of Pediatrics Division of Molecular Genetics, Naomi Berrie Diabetes Center
Richard Rausch rr2305@cumc.columbia.edu, Columbia University Department of Pediatrics Division of Molecular Genetics, Naomi Berrie Diabetes Center, New York, Mailing address: 1150 St. Nicholas Avenue Russ Berrie Pavilion Room 620 New York, NY 10033; Phone: 212 851 5315
Alicja A. Skowronski, aac2159@cumc.columbia.edu, Columbia University Institute of Human Nutrition, Columbia University Department of Pediatrics Division of Molecular Genetics, Naomi Berrie Diabetes Center
ISSN:0307-0565
1476-5497
1476-5497
DOI:10.1038/ijo.2016.238